+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Precision Medicine Software Market Forecast to 2033

  • PDF Icon

    Report

  • 100 Pages
  • October 2025
  • Region: Global
  • Grand View Research
  • ID: 6189413
The global precision medicine software market size was valued at USD 2.12 billion in 2024 and is projected to reach USD 5.66 billion by 2033, growing at a CAGR of 11.8% from 2025 to 2033. This growth is attributed to declining cost of genome sequencing, rise of targeted and personalized therapies, the increase of decentralized trials, and real-world evidence.

Moreover, government and institutional initiatives supporting genomics and precision medicine, and demand for personalized healthcare, have fueled the industry outlook. The declining cost of genome sequencing has transformed it from a high-cost, research-only tool into a routine part of clinical practice, making it a key driver of the precision medicine software industry. What once cost nearly USD 100 million per genome in the early 2000s can now be performed for under USD 500, enabling widespread adoption by hospitals, diagnostic labs, pharmaceutical companies, and even consumer health firms.

This affordability has led to a surge in large-scale genomic testing, generating massive datasets that require advanced software for storage, integration, and interpretation. Precision medicine software plays a central role in converting this raw sequencing data into actionable clinical insights for diagnosis, therapy selection, and patient stratification, driving demand as sequencing becomes standard in oncology, rare disease treatment, and preventive healthcare.

Global Precision Medicine Software Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global precision medicine software market report based on component, deployment mode, application, technology, therapeutic area, end use and region.

Component Outlook (Revenue, USD Million, 2021-2033)

  • Software
  • Services

Deployment Mode Outlook (Revenue, USD Million, 2021-2033)

  • Cloud-based
  • On-premise

Application Outlook (Revenue, USD Million, 2021-2033)

  • Genomic Data Management & Analysis
  • Multi-omics Analytics
  • Clinical Decision Support & Treatment Planning
  • Companion Diagnostics & Biomarker Discovery Tools
  • Clinical Trial Matching & Site Selection
  • Others (Population Genomics / Public-health Precision Tools)

Technology Outlook (Revenue, USD Million, 2021-2033)

  • AI / Machine Learning models & Generative AI
  • Rule-based engines (clinical guidelines, pathways)
  • Cloud & Containerized Pipelines (Kubernetes/Docker)
  • High-performance compute / HPC for genomics
  • Interoperability / FHIR / HL7 integration
  • Others (Data lakes & MDM (multi-modal data stores))

Therapeutic Area Outlook (Revenue, USD Million, 2021-2033)

  • Oncology
  • Cardiology
  • Neurology / CNS
  • Rare & Genetic Disorders
  • Infectious Diseases (pathogen genomics)
  • Immunology / Autoimmune
  • Others (dermatology, endocrinology)

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals
  • Pharmaceutical & Biotech companies
  • Diagnostic Laboratories & Genomic Service Providers
  • Contract Research Organizations (CROs)
  • Others (Research Institutes & Academic Centers)

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Report Deliverables

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Component
1.2.2. Deployment Mode
1.2.3. Application
1.2.4. Technology
1.2.5. Therapeutic Area
1.2.6. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Declining Cost of Genome Sequencing
3.2.1.2. Shift toward value-based and personalized care
3.2.1.3. Government and institutional initiatives supporting genomics and precision medicine
3.2.1.4. Rising patient awareness and demand for personalized healthcare
3.2.1.5. Maturing interoperability standards (FHIR, GA4GH, HL7)
3.2.1.6. Advances in AI and machine learning
3.2.2. Market Restraint Analysis
3.2.2.1. High implementation and maintenance costs
3.2.2.2. Integration challenges with legacy electronic health records
3.2.2.3. Shortage of skilled professionals in bioinformatics, genomics, and data science.
3.2.3. Industry Opportunity Analysis
3.2.4. Industry Challenge Analysis
3.2.5. Technology Overview
3.2.6. Case Studies
3.3. Business Environment Analysis
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal Landscape
Chapter 4. Precision Medicine Software Market: Component Estimates & Trend Analysis
4.1. Component Segment Dashboard
4.2. Component Market Share Movement Analysis, 2024 & 2033
4.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
4.4. Software
4.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Services
4.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.2. Implementation & integration
4.5.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.3. Clinical interpretation & reporting services
4.5.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.4. Validation & regulatory support
4.5.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.5. Data curation / annotation services
4.5.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.6. Others
4.5.6.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Precision Medicine Software Market: Deployment Mode Estimates & Trend Analysis
5.1. Deployment Mode Dashboard
5.2. Deployment Mode Market Share Movement Analysis, 2024 & 2033
5.3. Market Size & Forecasts and Trend Analysis, by Deployment Mode, 2021 to 2033 (USD Million)
5.4. Cloud Based
5.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5. on-Premise
5.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Precision Medicine Software Market: Application Estimates & Trend Analysis
6.1. Application Segment Dashboard
6.2. Application Market Share Movement Analysis, 2024 & 2033
6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Genomic Data Management & Analysis
6.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Multi-omics Analytics
6.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Clinical Decision Support & Treatment Planning
6.6.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.7. Companion Diagnostics & Biomarker Discovery Tools
6.7.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.8. Clinical Trial Matching & Site Selection
6.8.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.9. Others (Population Genomics / Public-health Precision Tools)
6.9.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Precision Medicine Software Market: Technology Estimates & Trend Analysis
7.1. Technology Dashboard
7.2. Technology Market Share Movement Analysis, 2024 & 2033
7.3. Market Size & Forecasts and Trend Analysis, by Technology, 2021 to 2033 (USD Million)
7.4. AI / Machine Learning models & Generative AI
7.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Rule-based engines (clinical guidelines, pathways)
7.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Cloud & Containerized Pipelines (Kubernetes/Docker)
7.6.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.7. High-performance compute / HPC for genomics
7.7.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.8. Interoperability / FHIR / HL7 integration
7.8.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.9. Others (Data lakes & MDM (multi-modal data stores))
7.9.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Precision Medicine Software Market: Therapeutic Area Estimates & Trend Analysis
8.1. Therapeutic Area Dashboard
8.2. Therapeutic Area Market Share Movement Analysis, 2024 & 2033
8.3. Market Size & Forecasts and Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Million)
8.4. Oncology
8.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.5. Cardiology
8.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.6. Neurology / CNS
8.6.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.7. Rare & Genetic Disorders
8.7.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.8. Infectious Diseases (pathogen genomics)
8.8.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.9. Immunology / Autoimmune
8.9.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.10. Others (dermatology, endocrinology)
8.10.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 9. Precision Medicine Software Market: End Use Estimates & Trend Analysis
9.1. End Use Segment Dashboard
9.2. End Use Market Share Movement Analysis, 2024 & 2033
9.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
9.4. Hospitals
9.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
9.5. Pharmaceutical & Biotech companies
9.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
9.6. Diagnostic Laboratories & Genomic Service Providers
9.6.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
9.7. Contract Research Organizations (CROs)
9.7.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
9.8. Others (Research Institutes & Academic Centers)
9.8.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 10. Precision Medicine Software Market: Regional Estimates & Trend Analysis
10.1. Regional Market Dashboard
10.2. Regional Market: Key Takeaways
10.3. North America
10.3.1. North America Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.3.2. U.S.
10.3.2.1. Key country dynamic
10.3.2.2. Regulatory framework
10.3.2.3. Competitive insights
10.3.2.4. U.S. Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.3.3. Canada
10.3.3.1. Key country dynamic
10.3.3.2. Regulatory framework
10.3.3.3. Competitive insights
10.3.3.4. Canada Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.3.4. Mexico
10.3.4.1. Key country dynamic
10.3.4.2. Regulatory framework
10.3.4.3. Competitive insights
10.3.4.4. Mexico Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.4. Europe
10.4.1. Europe Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.4.2. Germany
10.4.2.1. Key country dynamic
10.4.2.2. Regulatory framework
10.4.2.3. Competitive insights
10.4.2.4. Germany Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.4.3. UK
10.4.3.1. Key country dynamic
10.4.3.2. Regulatory framework
10.4.3.3. Competitive insights
10.4.3.4. UK Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.4.4. France
10.4.4.1. Key country dynamic
10.4.4.2. Regulatory framework
10.4.4.3. Competitive insights
10.4.4.4. France Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.4.5. Italy
10.4.5.1. Key country dynamic
10.4.5.2. Regulatory framework
10.4.5.3. Competitive insights
10.4.5.4. Italy Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.4.6. Spain
10.4.6.1. Key country dynamic
10.4.6.2. Regulatory framework
10.4.6.3. Competitive insights
10.4.6.4. Spain Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.4.7. Denmark
10.4.7.1. Key country dynamic
10.4.7.2. Regulatory framework
10.4.7.3. Competitive insights
10.4.7.4. Denmark Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.4.8. Sweden
10.4.8.1. Key country dynamic
10.4.8.2. Regulatory framework
10.4.8.3. Competitive insights
10.4.8.4. Sweden Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.4.9. Norway
10.4.9.1. Key country dynamic
10.4.9.2. Regulatory framework
10.4.9.3. Competitive insights
10.4.9.4. Norway Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.5. Asia Pacific
10.5.1. Asia Pacific Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.5.2. Japan
10.5.2.1. Key country dynamic
10.5.2.2. Regulatory framework
10.5.2.3. Competitive insights
10.5.2.4. Japan Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.5.3. China
10.5.3.1. Key country dynamic
10.5.3.2. Regulatory framework
10.5.3.3. Competitive insights
10.5.3.4. China Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.5.4. India
10.5.4.1. Key country dynamic
10.5.4.2. Regulatory framework
10.5.4.3. Competitive insights
10.5.4.4. India Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.5.5. South Korea
10.5.5.1. Key country dynamic
10.5.5.2. Regulatory framework
10.5.5.3. Competitive insights
10.5.5.4. South Korea Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.5.6. Australia
10.5.6.1. Key country dynamic
10.5.6.2. Regulatory framework
10.5.6.3. Competitive insights
10.5.6.4. Australia Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.5.7. Thailand
10.5.7.1. Key country dynamic
10.5.7.2. Regulatory framework
10.5.7.3. Competitive insights
10.5.7.4. Thailand Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.6. Latin America
10.6.1. Latin America Precision Medicine Software Market Estimates and Forecasts, 2021-2033 (USD Million)
10.6.2. Brazil
10.6.2.1. Key country dynamic
10.6.2.2. Regulatory framework
10.6.2.3. Competitive insights
10.6.2.4. Brazil Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.6.3. Argentina
10.6.3.1. Key country dynamic
10.6.3.2. Regulatory framework
10.6.3.3. Competitive insights
10.6.3.4. Argentina Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.7. MEA
10.7.1. MEA Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.7.2. South Africa
10.7.2.1. Key country dynamic
10.7.2.2. Regulatory framework
10.7.2.3. Competitive insights
10.7.2.4. South Africa Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.7.3. Saudi Arabia
10.7.3.1. Key country dynamic
10.7.3.2. Regulatory framework
10.7.3.3. Competitive insights
10.7.3.4. Saudi Arabia Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.7.4. UAE
10.7.4.1. Key country dynamic
10.7.4.2. Regulatory framework
10.7.4.3. Competitive insights
10.7.4.4. UAE Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
10.7.5. Kuwait
10.7.5.1. Key country dynamic
10.7.5.2. Regulatory framework
10.7.5.3. Competitive insights
10.7.5.4. Kuwait Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Chapter 11. Competitive Landscape
11.1. Participant Overview
11.2. Company Market Position Analysis/Company Market Share Analysis, (2024)
11.3. Company Categorization
11.4. Strategy Mapping
11.5. Company Profiles/Listing
11.5.1. OSP
11.5.1.1. Overview
11.5.1.2. Financial performance
11.5.1.3. Product benchmarking
11.5.1.4. Strategic initiatives
11.5.2. Genomind
11.5.2.1. Overview
11.5.2.2. Financial performance
11.5.2.3. Product benchmarking
11.5.2.4. Strategic initiatives
11.5.3. IQVIA
11.5.3.1. Overview
11.5.3.2. Financial performance
11.5.3.3. Product benchmarking
11.5.3.4. Strategic initiatives
11.5.4. Genedata AG
11.5.4.1. Overview
11.5.4.2. Financial performance
11.5.4.3. Product benchmarking
11.5.4.4. Strategic initiatives
11.5.5. SOPHiA GENETICS
11.5.5.1. Overview
11.5.5.2. Financial performance
11.5.5.3. Product benchmarking
11.5.5.4. Strategic initiatives
11.5.6. Tempus AI, Inc.
11.5.6.1. Overview
11.5.6.2. Financial performance
11.5.6.3. Product benchmarking
11.5.6.4. Strategic initiatives
11.5.7. Owkin, Inc.
11.5.7.1. Overview
11.5.7.2. Financial performance
11.5.7.3. Product benchmarking
11.5.7.4. Strategic initiatives
11.5.8. Syapse (acquired by N-Power in January 2025)
11.5.8.1. Overview
11.5.8.2. Financial performance
11.5.8.3. Product benchmarking
11.5.8.4. Strategic initiatives
11.5.9. Inspirata, Inc.
11.5.9.1. Overview
11.5.9.2. Financial performance
11.5.9.3. Product benchmarking
11.5.9.4. Strategic initiatives
11.5.10. Precision Medicine Group, LLC.
11.5.10.1. Overview
11.5.10.2. Financial performance
11.5.10.3. Product benchmarking
11.5.10.4. Strategic initiatives
11.5.11. Siemens
11.5.11.1. Overview
11.5.11.2. Financial performance
11.5.11.3. Product benchmarking
11.5.11.4. Strategic initiatives
11.5.12. GenomOncology LLC
11.5.12.1. Overview
11.5.12.2. Financial performance
11.5.12.3. Product benchmarking
11.5.12.4. Strategic initiatives
11.5.13. Qserve
11.5.13.1. Overview
11.5.13.2. Financial performance
11.5.13.3. Product benchmarking
11.5.13.4. Strategic initiatives
11.5.14. Foundation Medicine, Inc.
11.5.14.1. Overview
11.5.14.2. Financial performance
11.5.14.3. Product benchmarking
11.5.14.4. Strategic initiatives
11.5.15. PierianDx
11.5.15.1. Overview
11.5.15.2. Financial performance
11.5.15.3. Product benchmarking
11.5.15.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 List of secondary data sources
Table 3 North America Precision Medicine Software market, by country, 2021-2033 (USD Million)
Table 4 North America Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 5 North America Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 6 North America Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 7 North America Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 8 North America Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 9 North America Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 10 U.S. Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 11 U.S. Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 12 U.S. Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 13 U.S. Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 14 U.S. Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 15 U.S. Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 16 Canada Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 17 Canada Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 18 Canada Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 19 Canada Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 20 Canada Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 21 Canada Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 22 Mexico Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 23 Mexico Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 24 Mexico Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 25 Mexico Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 26 Mexico Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 27 Mexico Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 28 Europe Precision Medicine Software market, by country, 2021-2033 (USD Million)
Table 29 Europe Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 30 Europe Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 31 Europe Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 32 Europe Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 33 Europe Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 34 Europe Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 35 Germany Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 36 Germany Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 37 Germany Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 38 Germany Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 39 Germany Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 40 Germany Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 41 UK Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 42 UK Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 43 UK Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 44 UK Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 45 UK Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 46 UK Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 47 France Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 48 France Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 49 France Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 50 France Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 51 France Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 52 France Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 53 Italy Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 54 Italy Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 55 Italy Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 56 Italy Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 57 Italy Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 58 Italy Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 59 Spain Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 60 Spain Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 61 Spain Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 62 Spain Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 63 Spain Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 64 Spain Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 65 Sweden Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 66 Sweden Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 67 Sweden Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 68 Sweden Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 69 Sweden Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 70 Sweden Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 71 Denmark Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 72 Denmark Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 73 Denmark Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 74 Denmark Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 75 Denmark Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 76 Denmark Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 77 Norway Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 78 Norway Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 79 Norway Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 80 Norway Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 81 Norway Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 82 Norway Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 83 Asia-Pacific Precision Medicine Software market, by country, 2021-2033 (USD Million)
Table 84 Asia-Pacific Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 85 Asia-Pacific Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 86 Asia-Pacific Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 87 Asia-Pacific Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 88 Asia-Pacific Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 89 Asia-Pacific Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 90 China Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 91 China Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 92 China Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 93 China Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 94 China Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 95 China Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 96 Japan Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 97 Japan Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 98 Japan Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 99 Japan Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 100 Japan Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 101 Japan Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 102 India Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 103 India Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 104 India Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 105 India Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 106 India Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 107 India Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 108 Australia Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 109 Australia Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 110 Australia Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 111 Austarila Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 112 Austarila Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 113 Australia Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 114 Thailand Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 115 Thailand Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 116 Thailand Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 117 Thailand Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 118 Thailand Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 119 Thailand Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 120 South Korea Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 121 South Korea Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 122 South Korea Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 123 South Korea Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 124 South Korea Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 125 South Korea Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 126 Latin America Precision Medicine Software market, by country, 2021-2033 (USD Million)
Table 127 Latin America Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 128 Latin America Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 129 Latin America Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 130 Latin America Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 131 Latin America Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 132 Latin America Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 133 Brazil Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 134 Brazil Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 135 Brazil Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 136 Brazil Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 137 Brazil Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 138 Brazil Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 139 Argentina Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 140 Argentina Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 141 Argentina Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 142 Argentina Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 143 Argentina Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 144 Argentina Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 145 MEA Precision Medicine Software market, by country, 2021-2033 (USD Million)
Table 146 MEA Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 147 MEA Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 148 MEA Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 149 MEA Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 150 MEA Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 151 MEA Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 152 South Africa Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 153 South Africa Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 154 South Africa Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 155 South Africa Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 156 South Africa Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 157 South Africa Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 158 Saudi Arabia Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 159 Saudi Arabia Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 160 Saudi Arabia Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 161 Saudi Arabia Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 162 Saudi Arabia Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 163 Saudi Arabia Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 164 UAE Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 165 UAE Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 166 UAE Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 167 UAE Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 168 UAE Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 169 UAE Precision Medicine Software market, by end use, 2021-2033 (USD Million)
Table 170 Kuwait Precision Medicine Software market, by component, 2021-2033 (USD Million)
Table 171 Kuwait Precision Medicine Software market, by deployment mode, 2021-2033 (USD Million)
Table 172 Kuwait Precision Medicine Software market, by application, 2021-2033 (USD Million)
Table 173 Kuwait Precision Medicine Software market, by technology, 2021-2033 (USD Million)
Table 174 Kuwait Precision Medicine Software market, by therapeutic area, 2021-2033 (USD Million)
Table 175 Kuwait Precision Medicine Software market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Market formulation & validation
Figure 4 Precision Medicine Software market: Market outlook
Figure 5 Precision Medicine Software market: Segment outlook
Figure 6 Precision Medicine Software market: Competitive landscape outlook
Figure 7 Parent market outlook
Figure 8 Precision Medicine Software Market Driver Impact
Figure 9 Precision Medicine Software Market Restraint Impact
Figure 10 Precision Medicine Software Market, Component outlook key takeaways (USD Million)
Figure 11 Precision Medicine Software Market: Component movement analysis (USD Million)
Figure 12 Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 13 Services market estimates and forecasts, 2021-2033 (USD Million)
Figure 14 Implementation & integration market estimates and forecasts, 2021-2033 (USD Million)
Figure 15 Clinical interpretation & reporting services market estimates and forecasts, 2021-2033 (USD Million)
Figure 16 Validation & regulatory support market estimates and forecasts, 2021-2033 (USD Million)
Figure 17 Data curation / annotation services market estimates and forecasts, 2021-2033 (USD Million)
Figure 18 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 19 Precision Medicine Software Market, deployment mode outlook key takeaways (USD Million)
Figure 20 Precision Medicine Software Market: deployment mode movement analysis, (USD Million)
Figure 21 Cloud Based market estimates and forecasts, 2021-2033 (USD Million)
Figure 22 on-Premise market estimates and forecasts, 2021-2033 (USD Million)
Figure 23 Precision Medicine Software Market, application outlook: Key takeaways, (USD Million)
Figure 24 Precision Medicine Software Market: application movement analysis, (USD Million)
Figure 25 Genomic Data Management & Analysis market estimates and forecasts, 2021-2033 (USD Million)
Figure 26 Multi-omics Analytics market estimates and forecasts, 2021-2033 (USD Million)
Figure 27 Clinical Decision Support & Treatment Planning market estimates and forecasts, 2021-2033 (USD Million)
Figure 28 Companion Diagnostics & Biomarker Discovery Tools market estimates and forecasts, 2021-2033 (USD Million)
Figure 29 Clinical Trial Matching & Site Selection market estimates and forecasts, 2021-2033 (USD Million)
Figure 30 Others (Population Genomics / Public-health Precision Tools) market estimates and forecasts, 2021-2033 (USD Million)
Figure 31 Precision Medicine Software Market, technology outlook key takeaways (USD Million)
Figure 32 Precision Medicine Software Market technology movement analysis, (USD Million)
Figure 33 AI / Machine Learning models & Generative AI market estimates and forecasts, 2021-2033 (USD Million)
Figure 34 Rule-based engines (clinical guidelines, pathways) market estimates and forecasts, 2021-2033 (USD Million)
Figure 35 Cloud & Containerized Pipelines (Kubernetes/Docker) market estimates and forecasts, 2021-2033 (USD Million)
Figure 36 High-performance compute / HPC for genomics market estimates and forecasts, 2021-2033 (USD Million)
Figure 37 Interoperability / FHIR / HL7 integration market estimates and forecasts, 2021-2033 (USD Million)
Figure 38 Others (Data lakes & MDM (multi-modal data stores)) market estimates and forecasts, 2021-2033 (USD Million)
Figure 39 Precision Medicine Software Market, therapeutic area outlook key takeaways (USD Million)
Figure 40 Precision Medicine Software Market: therapeutic area movement analysis, (USD Million)
Figure 41 Oncology market estimates and forecasts, 2021-2033 (USD Million)
Figure 42 Cardiology market estimates and forecasts, 2021-2033 (USD Million)
Figure 43 Neurology/CNS market estimates and forecasts, 2021-2033 (USD Million)
Figure 44 Rare & Genetic Disorders market estimates and forecasts, 2021-2033 (USD Million)
Figure 45 Infectious Diseases (pathogen genomics) market estimates and forecasts, 2021-2033 (USD Million)
Figure 46 Immunology/Autoimmune market estimates and forecasts, 2021-2033 (USD Million)
Figure 47 Others (dermatology, endocrinology) market estimates and forecasts, 2021-2033 (USD Million)
Figure 48 Precision Medicine Software Market, end use outlook key takeaways (USD Million)
Figure 49 Precision Medicine Software Market: end use movement analysis, (USD Million)
Figure 50 Hospitals market estimates and forecasts, 2021-2033 (USD Million)
Figure 51 Pharmaceutical & Biotech companies market estimates and forecasts, 2021-2033 (USD Million)
Figure 52 Diagnostic Laboratories & Genomic Service Providers market estimates and forecasts, 2021-2033 (USD Million)
Figure 53 Contract Research Organizations (CROs) market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Others (Research Institutes & Academic Centers) market estimates and forecasts, 2021-2033 (USD Million)
Figure 55 Regional marketplace: Key takeaways
Figure 56 Precision Medicine Software market: Regional outlook, 2024 & 2033
Figure 57 North America Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 58 U.S. Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 59 Canada Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 60 Mexico Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 61 Europe Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 62 UK Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 63 Germany Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 64 France Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 65 Italy Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 66 Spain Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 67 Denmark Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 68 Sweden Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 69 Norway Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 Asia-Pacific Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 71 Japan Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 China Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 73 India Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 South Korea Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 75 Australia Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 Thailand Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 77 Latin America Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 78 Brazil Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 79 Argentina Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 80 MEA Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 81 South Africa Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 82 Saudi Arabia Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 83 UAE Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 84 Kuwait Precision Medicine Software market estimates and forecasts, 2021-2033 (USD Million)

Companies Mentioned

The companies profiled in this Precision Medicine Software market report include:
  • OSP
  • Genomind
  • IQVIA
  • Genedata AG
  • SOPHiA GENETICS
  • Tempus AI, Inc.
  • Owkin, Inc
  • Syapse (acquired by N-Power in January 2025)
  • Inspirata, Inc.
  • Precision Medicine Group, LLC.
  • Siemens
  • GenomOncology LLC
  • Qserve
  • Foundation Medicine, Inc.
  • PierianDx

Table Information